Gastroenterology

Gastroenterology Seminar CME / CPD 

Full Course:  20 AMA PRA Category I Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category I Credits for CME / CEU / CPD

Course(s) are appropriate for:  Gastroenterologists, Internal Medicine Physicians, Subspecialist Physicians, General Practitioners, Nurses, Nurse Practitioners

Series 41 (GI41) Topics Include: NASH and Acute Liver Failure, Liver Transplantation, Motility, Pancreatitis Update, IBD, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
GI41
Full Course Price:
$580
Short Course:
GI41A, GI41B
Short Course Price:
$485
Format:
Available in Audio format.

Course Topics

Managing Colonic Diseases

Use fecal microbiota transplantation to treat patients with recurrent Clostridium difficile infection, inflammatory bowel disease, irritable bowel syndrome, and metabolic syndrome; Weigh the advantages and disadvantages of antibiotic therapy and fecal microbiota transplantation in the management of Clostridium difficile infection; Diagnose complications related to ileal pouch-anal anastomosis using clinical and endoscopic findings; Manage complications of ileal pouch-anal anastomosis using endoscopic findings and markers of inflammation; Select surgical techniques for management of anal horseshoe fistulas based on patient history and anatomic abnormalities.

NASH and Acute Liver Failure

Identify clinical and histologic risk factors for NASH; Discuss the benefits and drawbacks of liver biopsy for identification of NASH in patients with nonalcoholic fatty liver disease (NAFLD); Estimate the accuracy of noninvasive methods for predicting liver fibrosis in patients with NAFLD; Summarize potential targets for pharmaceutical treatment of NASH; Manage patients with hepatic obstruction based on degree of veno-occlusion and severity of liver disease.

Pancreatitis Update

Diagnose autoimmune pancreatitis; Prescribe therapy for autoimmune pancreatitis and immunoglobulin G4-associated cholangiopathy; Select patients who would benefit from endoscopic retrograde cholangiopancreatography; Identify manifestations of idiopathic pancreatitis; Analyze the relationship between pancreas divisum and pancreatitis.

Alcoholic Hepatitis/Cirrhosis

Diagnose and assess the severity of alcoholic hepatitis; Counsel patients with alcoholic hepatitis about diet and nutrition; Consider treatment with steroids in patients with alcoholic hepatitis; List the causes of infection in patients with cirrhosis; Plan an effective course of treatment for sepsis in patients with cirrhosis.

Pancreatic Cancer

Implement surveillance in patients with pancreatic cysts; Select patients for surgical management of pancreatic cysts based on growth rate, cytologic findings, and molecular markers; Recognize genetic and behavioral risk factors for pancreatic cancer; Choose screening tests for pancreatic cancer based on efficacy and safety Treat patients with pancreatic cancer based on resectability of tumors.

Esophageal Update

Diagnose patients with eosinophilic esophagitis using endoscopy and esophageal impedance pH monitoring; Optimize the use of current therapies for patients with eosinophilic esophagitis; Recognize why patients with symptoms of gastroesophageal reflux disease may not respond to therapy using proton pump inhibitors; Assess risk for esophageal adenocarcinoma based on patients' characteristics and symptoms of gastroesophageal reflux disease or the presence of Barrett esophagus; Perform endoscopic surveillance at appropriate intervals based on risk for esophageal adenocarcinoma.

Inflammatory Bowel Disease Update

Use the findings of colonoscopy and noninvasive testing to assess disease activity in patients with inflammatory bowel disease; Recognize risk factors and treatment options for patients with microscopic colitis; Monitor disease activity in patients with inflammatory bowel disease; Weigh the risks and benefits of immunosuppressive therapy in patients with both inflammatory bowel disease and liver disease; Prescribe treatment regimens for inflammatory bowel disease in patients with viral hepatitis, cirrhosis, and liver transplantation.

Motility Update

Provide recommendations for behavior modification and stress management to improve gastrointestinal conditions that impair quality of life; Select behavioral interventions that have been shown to improve symptoms of gastrointestinal disease and related coping mechanisms; Explain the role and rationale for motility testing in gastroenterology practices; Choose motility tests based on safety, invasiveness, effect on outcome, and insurance reimbursement; Identify the cause and source of diarrhea using stool tests, biopsy, culture, and endoscopy.

Liver Transplantation 2017

Analyze recent data on the association between obesity and outcomes of hepatic resection and liver transplantation; Apply standardized approaches for weight loss in the treatment of obese candidates for liver transplantation; Explain the allocation of donor organs based on assessment of need and predicted survival rate after transplantation; Recognize the benefits and drawbacks of recent policy changes for improving access to liver transplantation; Assess potential sources of donors in liver transplantation to reduce the gap between supply and demand.

Inflammatory Bowel Disease in Special Populations

Modify treatment for elderly patients with IBD based on their fitness and treatment-related side effects; Predict which patients with IBD may have impaired fertility based on ovarian reserve and previous colorectal surgeries; Discuss preconception and prenatal management of IBD with patients who plan to become pregnant; Determine which vaccinations are safe for patients with IBD based on age, level of immunosuppression, and vaccination history; Monitor patients with IBD for cancer risk, venous thromboembolism, osteoporosis, and vitamin and mineral deficiencies.

NASH and Acute Liver Failure

Identify clinical and histologic risk factors for NASH; Discuss the benefits and drawbacks of liver biopsy for identification of NASH in patients with nonalcoholic fatty liver disease (NAFLD); Estimate the accuracy of noninvasive methods for predicting liver fibrosis in patients with NAFLD; Summarize potential targets for pharmaceutical treatment of NASH; Manage patients with hepatic obstruction based on degree of veno-occlusion and severity of liver disease.

Alcoholic Hepatitis/Cirrhosis

Diagnose and assess the severity of alcoholic hepatitis; Counsel patients with alcoholic hepatitis about diet and nutrition; Consider treatment with steroids in patients with alcoholic hepatitis; List the causes of infection in patients with cirrhosis; Plan an effective course of treatment for sepsis in patients with cirrhosis.

Esophageal Update

Diagnose patients with eosinophilic esophagitis using endoscopy and esophageal impedance pH monitoring; Optimize the use of current therapies for patients with eosinophilic esophagitis; Recognize why patients with symptoms of gastroesophageal reflux disease may not respond to therapy using proton pump inhibitors; Assess risk for esophageal adenocarcinoma based on patients' characteristics and symptoms of gastroesophageal reflux disease or the presence of Barrett esophagus; Perform endoscopic surveillance at appropriate intervals based on risk for esophageal adenocarcinoma.

Motility Update

Provide recommendations for behavior modification and stress management to improve gastrointestinal conditions that impair quality of life; Select behavioral interventions that have been shown to improve symptoms of gastrointestinal disease and related coping mechanisms; Explain the role and rationale for motility testing in gastroenterology practices; Choose motility tests based on safety, invasiveness, effect on outcome, and insurance reimbursement; Identify the cause and source of diarrhea using stool tests, biopsy, culture, and endoscopy.

Liver Transplantation 2017

Analyze recent data on the association between obesity and outcomes of hepatic resection and liver transplantation; Apply standardized approaches for weight loss in the treatment of obese candidates for liver transplantation; Explain the allocation of donor organs based on assessment of need and predicted survival rate after transplantation; Recognize the benefits and drawbacks of recent policy changes for improving access to liver transplantation; Assess potential sources of donors in liver transplantation to reduce the gap between supply and demand.

Managing Colonic Diseases

Use fecal microbiota transplantation to treat patients with recurrent Clostridium difficile infection, inflammatory bowel disease, irritable bowel syndrome, and metabolic syndrome; Weigh the advantages and disadvantages of antibiotic therapy and fecal microbiota transplantation in the management of Clostridium difficile infection; Diagnose complications related to ileal pouch-anal anastomosis using clinical and endoscopic findings; Manage complications of ileal pouch-anal anastomosis using endoscopic findings and markers of inflammation; Select surgical techniques for management of anal horseshoe fistulas based on patient history and anatomic abnormalities.

Pancreatitis Update

Diagnose autoimmune pancreatitis; Prescribe therapy for autoimmune pancreatitis and immunoglobulin G4-associated cholangiopathy; Select patients who would benefit from endoscopic retrograde cholangiopancreatography; Identify manifestations of idiopathic pancreatitis; Analyze the relationship between pancreas divisum and pancreatitis.

Pancreatic Cancer

Implement surveillance in patients with pancreatic cysts; Select patients for surgical management of pancreatic cysts based on growth rate, cytologic findings, and molecular markers; Recognize genetic and behavioral risk factors for pancreatic cancer; Choose screening tests for pancreatic cancer based on efficacy and safety Treat patients with pancreatic cancer based on resectability of tumors.

Inflammatory Bowel Disease Update

Use the findings of colonoscopy and noninvasive testing to assess disease activity in patients with inflammatory bowel disease; Recognize risk factors and treatment options for patients with microscopic colitis; Monitor disease activity in patients with inflammatory bowel disease; Weigh the risks and benefits of immunosuppressive therapy in patients with both inflammatory bowel disease and liver disease; Prescribe treatment regimens for inflammatory bowel disease in patients with viral hepatitis, cirrhosis, and liver transplantation.

Inflammatory Bowel Disease in Special Populations

Modify treatment for elderly patients with IBD based on their fitness and treatment-related side effects; Predict which patients with IBD may have impaired fertility based on ovarian reserve and previous colorectal surgeries; Discuss preconception and prenatal management of IBD with patients who plan to become pregnant; Determine which vaccinations are safe for patients with IBD based on age, level of immunosuppression, and vaccination history; Monitor patients with IBD for cancer risk, venous thromboembolism, osteoporosis, and vitamin and mineral deficiencies.

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include:  Internal MedicineObesityEndocrinology and Metabolic DisordersDiabetes

If you have taken the current Gastroenterology CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon.  There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.

For over 30 years, ASI has provided Continuing Medical Education, CME & CEU and Continuing Professional Development Education (CPD) for physicians and allied professionals in Gastroenterology plus over 40 other specialties and subspecialties.  Lectures are recorded annually at the top seminars and conferences to provide the most current medical education to our clients.